Skip to main content

Loading market ticker...

Alivus Life Sciences

Healthcare NSE:ALIVUS

1335.80INR
121.40 ( 10.00%)

Last update at Aug. 4, 2026, 4:04 p.m.

Day Range

1201.201358.00
LowHigh

52 Week Range

847.20 1089.20
LowHigh

Fundamentals

  • Previous Close 1214.40
  • Market Cap 110719.21M
  • Volume1,241,662
  • P/E Ratio 20.91
  • EBITDA 7364.08M
  • Revenue TTM 24812.15M
  • Revenue Per Share TTM 202.37
  • Gross Profit TTM 13441.39M
  • Diluted EPS TTM 43.16

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 6541.31M 6312.90M 6286.09M 5649.25M 4709.44M
Net income 4856.27M 4708.88M 4669.61M 4187.24M 3515.81M
Total Revenue 23718.93M 21847.70M 20478.40M 20874.48M 18613.95M
Gross Profit 7638.46M 11640.69M 10164.95M 10297.49M 9457.08M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 34114.53M 28504.12M 27021.47M 24710.07M 19970.75M
Intangible assets 199.37M 148.52M 180.01M 103.80M 79.11M
Other current assets 1029.29M 5.18M 6.43M 567.84M -
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -2303.52M 175.91M -2283.34M 3965.61M 1055.98M
Operating Cash 4114.20M 4135.15M 3060.06M 5975.85M 3881.13M
Free Cash Flow 2452.33M 2845.46M 1432.08M 4654.13M 3201.20M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
ALIVUS
Alivus Life Sciences 		121.40 10.00% 1335.80 110719.21 20.91
SUNPHARMA
Sun Pharmaceutical Industries Limited 		0.50 0.03% 1964.00 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-207.00 -2.41% 8378.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-20.00 -0.40% 5030.00 1362716.66 63.48
CIPLA
Cipla Limited 		-14.40 -0.98% 1460.00 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.